glp-1 drug exposure pharmaceutical companies 2025 SUSTAINABLE DELIVERY: FUTURE-PROOFING THERAPY ADMINISTRATION FOR OBESITY AND BEYOND Top companies and drugs by

You have to make sure you're not losing muscle mass, you have to make sure you're getting your nutrients

These findings suggest that, in addition to its role in modulating immune responses, exenatide confers neuroprotection by alleviating ER stress, thus preserving cellular integrity and supporting functional recovery

Analysts say the move could intensify competition in a market already dominated by blockbuster GLP-1 drugs and reshape how obesity is treated in primary care

Retrieved 25 August 2025

In 2020 the first small-molecule structure (Zhao et al) revealed a druggable transmembrane sub-pocket distinct from the peptide-binding interface